Tags

Type your tag names separated by a space and hit enter

Cost analysis of intensive glycemic control in critically ill adult patients.
Chest. 2006 Mar; 129(3):644-50.Chest

Abstract

STUDY OBJECTIVES

To assess the effect of an intensive glycemia management protocol on the cost of care of a heterogeneous population of critically ill adult patients.

DESIGN

Economic analysis of a 1,600-patient "before-and-after" study of intensive glycemia management.

SETTING

Fourteen-bed mixed medical-surgical adult ICU of a university-affiliated community teaching hospital.

PATIENTS

Eight hundred consecutive admissions to the ICU prior to the institution of an intensive glucose management protocol were compared to the first 800 patients admitted to the ICU following institution of the protocol.

INTERVENTIONS

Cost data were analyzed using the comprehensive database of the ICU as well as other hospital data repositories.

MEASUREMENTS AND RESULTS

The ICU database was used to quantify the major components of the cost of care. The analysis includes costs associated with ICU and non-ICU patient days, ventilator days, and laboratory, pharmacy, and radiology services. Comparing the baseline and treatment periods, there were decreases in patient days in the ICU; ventilator days; total laboratory, pharmacy and radiology costs; and post-ICU hospital length of stay. The net annualized decrease in costs during the treatment period was USD 1,339,500, or USD 1,580 per patient.

CONCLUSIONS

The institution of a program to intensively monitor glucose levels and treat even modest hyperglycemia in the ICU was associated with substantial cost savings. This finding, in conjunction with the previously demonstrated improvement in mortality and morbidity, strongly supports the adoption of this intervention as a standard of care in the ICU.

Authors+Show Affiliations

Director of Critical Care, Stamford Hospital, 190 West Broad St, Stamford, CT 06902, USA. jkrinsley@stamhealth.orgNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

16537863

Citation

Krinsley, James Stephen, and Richard L. Jones. "Cost Analysis of Intensive Glycemic Control in Critically Ill Adult Patients." Chest, vol. 129, no. 3, 2006, pp. 644-50.
Krinsley JS, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest. 2006;129(3):644-50.
Krinsley, J. S., & Jones, R. L. (2006). Cost analysis of intensive glycemic control in critically ill adult patients. Chest, 129(3), 644-50.
Krinsley JS, Jones RL. Cost Analysis of Intensive Glycemic Control in Critically Ill Adult Patients. Chest. 2006;129(3):644-50. PubMed PMID: 16537863.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cost analysis of intensive glycemic control in critically ill adult patients. AU - Krinsley,James Stephen, AU - Jones,Richard L, PY - 2006/3/16/pubmed PY - 2006/4/28/medline PY - 2006/3/16/entrez SP - 644 EP - 50 JF - Chest JO - Chest VL - 129 IS - 3 N2 - STUDY OBJECTIVES: To assess the effect of an intensive glycemia management protocol on the cost of care of a heterogeneous population of critically ill adult patients. DESIGN: Economic analysis of a 1,600-patient "before-and-after" study of intensive glycemia management. SETTING: Fourteen-bed mixed medical-surgical adult ICU of a university-affiliated community teaching hospital. PATIENTS: Eight hundred consecutive admissions to the ICU prior to the institution of an intensive glucose management protocol were compared to the first 800 patients admitted to the ICU following institution of the protocol. INTERVENTIONS: Cost data were analyzed using the comprehensive database of the ICU as well as other hospital data repositories. MEASUREMENTS AND RESULTS: The ICU database was used to quantify the major components of the cost of care. The analysis includes costs associated with ICU and non-ICU patient days, ventilator days, and laboratory, pharmacy, and radiology services. Comparing the baseline and treatment periods, there were decreases in patient days in the ICU; ventilator days; total laboratory, pharmacy and radiology costs; and post-ICU hospital length of stay. The net annualized decrease in costs during the treatment period was USD 1,339,500, or USD 1,580 per patient. CONCLUSIONS: The institution of a program to intensively monitor glucose levels and treat even modest hyperglycemia in the ICU was associated with substantial cost savings. This finding, in conjunction with the previously demonstrated improvement in mortality and morbidity, strongly supports the adoption of this intervention as a standard of care in the ICU. SN - 0012-3692 UR - https://www.unboundmedicine.com/medline/citation/16537863/Cost_analysis_of_intensive_glycemic_control_in_critically_ill_adult_patients_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0012-3692(15)52266-6 DB - PRIME DP - Unbound Medicine ER -